Saroja Pharma Industries India Q4 Results
- BSE: -
- NSE: SAROJA
- ISIN: INE0PCL01011
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
38.95
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Wed 2 Sep, 2026 | 14:01:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹31.77 Cr.(-9.24%)
- Operating Profit₹2.68 Cr.(68.53%)
- Profit After Tax₹1.05 Cr.(50.20%)
- Operating Margin8.44%(NA%)
Note: Comparison is on YoY basis
Quarterly - Saroja Pharma Industries India Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | - | QoQ Comp | Mar 25 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 29.09 | - | N/A | 33.41 | -12.94% |
| Depreciation/ Amortization | 0.05 | - | N/A | 0.06 | -18.75% |
| Operating Income | 2.68 | - | N/A | 1.59 | 68.53% |
| Net Income | 1.05 | - | N/A | 0.70 | 50.20% |
| Other Operating Expenses Total | 0.82 | - | N/A | 0.51 | 60.34% |
| Net Income Before Taxes | 1.46 | - | N/A | 0.98 | 47.80% |
| Total Revenue | 31.77 | - | N/A | 35.00 | -9.24% |
| Selling/ General/ Admin Expenses Total | 0.57 | - | N/A | 0.69 | -16.36% |
| Diluted Normalized EPS | 2.60 | - | N/A | 1.75 | 48.83% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.